Conclusion
摘要
Even though the diagnosis of ARFID was new to the DSM-5 in 2013, it has been present long before that. Increased awareness of the existence of ARFID has resulted in better identification and more individuals and their families seeking treatment. With this formal diagnosis comes opportunities for ongoing treatment design and research to determine gold standard practices It is our belief that ARFID treatment is most successful when it is customized to the individual. While ARFID and other restrictive eating disorders can result in malnutrition, the process, type, and execution of the nutrition plan is incredibly individualized and varied. Moreover, there is a difference in presentations amongst ARFID subtypes and patients within each subtype or subtypes can have specific needs.